Kotra Industries BhdXKLS:0002 +0.27%84 Return-on-Tangible-Equity is 11.36% as of Mar. 2026, which is 21% below its 10-year median of 14.47. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.34 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 897 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 67.11% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Kotra Industries Bhd's annualized net income for the quarter that ended in Mar. 2026 was RM32.4 Mil. Kotra Industries Bhd's average shareholder tangible equity for the quarter that ended in Mar. 2026 was RM285.1 Mil. Therefore, Kotra Industries Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 11.36%.
The historical rank and industry rank for Kotra Industries Bhd's Return-on-Tangible-Equity or its related term are showing as below:
XKLS:0002'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 6.14 Med: 14.47 Max: 27.56
Current: 13.51
During the past 13 years, Kotra Industries Bhd's highest Return-on-Tangible-Equity was 27.56%. The lowest was 6.14%. And the median was 14.47%.
XKLS:0002's Return-on-Tangible-Equity is ranked better than 67.11% of 897
companies
in the Drug Manufacturers industry
Industry Median: 7.9
vs XKLS:0002: 13.51
Kotra Industries Bhd (XKLS:0002) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Kotra Industries Bhd Return-on-Tangible-Equity Related Terms
Kotra Industries Bhd Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kotra Industries Bhd Return-on-Tangible-Equity Chart
XKLS:0002 vs ZTS, UTHR, VTRS: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 11.36% mean?
Kotra Industries Bhd (XKLS:0002) has a Return-on-Tangible-Equity of 11.36% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kotra Industries Bhd and its competitors. This is 21% below median its historical median of 14.47. Over the past decade, Kotra Industries Bhd's Return-on-Tangible-Equity has ranged from 6.14 to 27.56. According to the industry distribution chart, Kotra Industries Bhd ranks #295 out of 897 companies in the Drug Manufacturers industry, placing it in the top 32.9%.
Is Kotra Industries Bhd's Return-on-Tangible-Equity too high?
Kotra Industries Bhd's current Return-on-Tangible-Equity of 11.36% is 21% below median its 10-year median of 14.47. Over the past 10 years, this metric has ranged from a low of 6.14 to a high of 27.56. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.90. Kotra Industries Bhd's value of 11.36% is 43.8% above this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #295 out of 897 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #295 out of 897 companies for Return-on-Tangible-Equity. This puts Kotra Industries Bhd in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.90. Kotra Industries Bhd's value of 11.36% is 43.8% above this benchmark. Historically, Kotra Industries Bhd's own Return-on-Tangible-Equity has ranged from 6.14 to 27.56 over the past decade. While the company's 10-year median is 14.47 vs. the industry median of 7.90, Kotra Industries Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.90, based on 897 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current Return-on-Tangible-Equity of 11.36% is 43.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current Return-on-Tangible-Equity is 11.36%, which is 21% below median its own 10-year median of 14.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.34, compared to a current price of RM3.73 — trading 14.1% below its estimated fair value. The current Return-on-Tangible-Equity is 11.36%, which is 21% below median its 10-year median of 14.47 and 43.8% above the Drug Manufacturers industry median of 7.90. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Return-on-Tangible-Equity is 11.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.73 is trading 14.1% below its estimated GF Value™ of RM4.34.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
Return-on-Tangible-Equity: 11.36% (21% below median its 10-year median of 14.47)
GF Value™: RM4.34 vs. price of RM3.73 (14.1% below fair value)
Industry Position: 43.8% above the Drug Manufacturers median (#295 of 897)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score
Get the complete analysis for XKLS:0002
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
